Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity and safety of tixagevimab-cilgavimab for COVID-19 pre-exposure prophylaxis in immunocompromised 20 to <40 kg children and adolescents: A pilot, prospective, open-labeled study.
Buaboonnam J, Rungmaitree S, Piyaphanee N, Charuvanij S, Pitisuttithum O, Copeland K, Pheerapanyawaranun C, Jansarikit L, Niyomnaitham S, Chokephaibulkit K. Buaboonnam J, et al. Among authors: pheerapanyawaranun c. Hum Vaccin Immunother. 2024 Dec 31;20(1):2428011. doi: 10.1080/21645515.2024.2428011. Epub 2024 Nov 22. Hum Vaccin Immunother. 2024. PMID: 39575846 Free PMC article.
Immunogenicity of BNT162b2 as a first booster after a ChAdOx1 primary series in a Thai geriatric population living with frailty.
Niyomnaitham S, Chokephaibulkit K, Pheerapanyawaranun C, Toh ZQ, Licciardi PV, Satayasanskul A, Jansarikit L, Assantachai P. Niyomnaitham S, et al. Among authors: pheerapanyawaranun c. J Nutr Health Aging. 2024 Aug;28(8):100315. doi: 10.1016/j.jnha.2024.100315. Epub 2024 Jul 17. J Nutr Health Aging. 2024. PMID: 39025017 Free article. Clinical Trial.
Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis.
Soe KK, Krikeerati T, Pheerapanyawaranun C, Niyomnaitham S, Phinyo P, Thongngarm T. Soe KK, et al. Among authors: pheerapanyawaranun c. Front Pharmacol. 2023 May 23;14:1184552. doi: 10.3389/fphar.2023.1184552. eCollection 2023. Front Pharmacol. 2023. PMID: 37288109 Free PMC article. Review.
Binding and neutralizing antibody levels and vaccine efficacy/effectiveness compared between heterologous and homologous primary series COVID-19 vaccination: A systematic review and meta-analysis.
Angkasekwinai N, Prawjaeng J, Leelahavarong P, Khuntha S, Pheerapanyawaranun C, Chitpim N, Srinonprasert V, Chokephaibulkit K. Angkasekwinai N, et al. Among authors: pheerapanyawaranun c. Asian Pac J Allergy Immunol. 2022 Dec;40(4):321-336. doi: 10.12932/AP-121122-1501. Asian Pac J Allergy Immunol. 2022. PMID: 36681658 Free article.
Monitoring and Evaluation of National Vaccination Implementation: A Scoping Review of How Frameworks and Indicators Are Used in the Public Health Literature.
Marzouk M, Omar M, Sirison K, Ananthakrishnan A, Durrance-Bagale A, Pheerapanyawaranun C, Porncharoen C, Pimsarn N, Lam ST, Ung M, Mougammadou Aribou Z, Dabak SV, Isaranuwatchai W, Howard N. Marzouk M, et al. Among authors: pheerapanyawaranun c. Vaccines (Basel). 2022 Apr 6;10(4):567. doi: 10.3390/vaccines10040567. Vaccines (Basel). 2022. PMID: 35455316 Free PMC article. Review.
A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings.
Teerawattananon Y, Anothaisintawee T, Pheerapanyawaranun C, Botwright S, Akksilp K, Sirichumroonwit N, Budtarad N, Isaranuwatchai W. Teerawattananon Y, et al. Among authors: pheerapanyawaranun c. PLoS One. 2022 Jan 11;17(1):e0261930. doi: 10.1371/journal.pone.0261930. eCollection 2022. PLoS One. 2022. PMID: 35015761 Free PMC article.